融合表达氨基转移酶DsaD和异构酶DsaE合成L-别异亮氨酸

【背景】L-异亮氨酸(L-isoleucine,L-Ile)和L-别异亮氨酸(L-allo-isoleucine,L-allo-Ile)是自然界中广泛存在的一对同分异构体。抗感染抗生素Desotamides结构中含L-别异亮氨酸结构单元,其生物合成途径中的氨基转移酶DsaD和异构酶DsaE可以协作催化L-异亮氨酸和L-别异亮氨酸相互转化。【目的】通过理性设计,使氨基转移酶DsaD和异构酶DsaE融合表达,研究融合蛋白DsaDE催化异亮氨酸和别异亮氨酸相互转化的功能。【方法】利用PCR分别扩增dsaE基因编码区DNA片段、以及含dsaD基因编码区和114个碱基接头序列的DNA片段dsaD-linker,利用酶切位点KpnI将dsaE和dsaD-linker相连,形成das DE重组序列,并克隆至pET28a(+)中,将重组质粒pET28a-dsaDE转化至Escherichia coli BL21(DE3)中进行融合表达,利用Ni-NTA亲和层析法纯化融合蛋白DsaDE;分别以L-异亮氨酸和L-别异亮氨酸为底物进行融合蛋白的体外酶活性检测,利用高效液相色谱对酶反应产物进行分析。【结果】PCR验证、酶切验证以及测序结果证明pET28a-dsaDE重组载体具有正确序列;N-末端和C-末端融合6个组氨酸标签的融合蛋白DsaDE在E. coli BL21(DE3)中获得可溶性表达,经Ni-NTA亲和层析法一步纯化获得纯度约95%的融合蛋白,纯化的融合蛋白DsaDE具有较好的活性,能够催化L-isoleucine和L-allo-isoleucine间的相互转化。【结论】氨基转移酶DsaD和异构酶DsaE成功融合表达,经一步Ni-NTA亲和层析法纯化即可获得纯度较高的融合蛋白,融合蛋白同时具有氨基转移酶和异构酶的活性,为进一步研究L-别异亮氨酸的工业化生产奠定了基础。     

定点突变改变近平滑假丝酵母SCRⅡ催化苯乙酮衍生物底物谱

【目的】通过定点突变技术,改变近平滑假丝酵母短链羰基还原酶Ⅱ(SCRⅡ)催化苯乙酮衍生物的功能,为数种手性芳香醇的生产提供一种高效、安全的新型制备方法。【方法】通过氨基酸序列和蛋白结构比对的方法,选择SCRⅡ的底物结合域中关键氨基酸位点E228实施突变,构建相应的突变株Escherichia coliBL21/pET28a-E228S;以苯乙酮衍生物为底物,对突变株的酶活和生物转化功能进行了分析。【结果】酶活测定结果表明:突变株E.coli BL21/pET28a-E228S催化原始底物2-羟基苯乙酮的酶活仅为原始酶活的25%左右;而催化苯乙酮、4’-甲基苯乙酮、4’-氯苯乙酮的酶活是突变前的7-20倍。突变株E.coli BL21/pET28a-E228S生物转化2-羟基苯乙酮,获得产物(S)-苯基乙二醇的得率不超过10%,而以苯乙酮、4’-甲基苯乙酮、4’-氯苯乙酮为底物时,生物转化产物光学纯度维持在99%,得率高达80%以上。【结论】对底物结合域中的关键氨基酸实施突变,提高了SCRⅡ催化苯乙酮衍生物的底物广谱性,拓展了该酶的生物功能,为理性改造短链羰基还原酶的不对称还原催化功能和手性芳香醇的制备提供了新型途径。     

友菌素核苷转移酶amiE基因的克隆、表达和功能鉴定

【目的】克隆和表达二糖核苷类抗生素友菌素生物合成基因簇中的核苷转移酶基因amiE,并研究AmiE的体外催化功能。【方法】采用PCR技术将编码257个氨基酸的葡萄糖-1-磷酸核苷转移酶基因amiE克隆到表达载体pET28a上,构建质粒pCSG4001,转化入大肠杆菌E.coli BL21(DE3)中诱导表达;利用亲和层析分离纯化蛋白AmiE,以葡萄糖-1-磷酸和胸腺嘧啶三磷酸(TTP)或尿嘧啶三磷酸(UTP)为底物,利用高效液相检测AmiE的体外酶活;以甘露糖-1-磷酸、半乳糖胺-1-磷酸和半乳糖-1-磷酸和TTP作为底物,进一步研究AmiE对底物的选择性。【结果】N-末端融合组氨酸标签的AmiE蛋白在大肠杆菌中获得了可溶性表达,通过亲和层析纯化出的AmiE能够以TTP(或UTP)和葡萄糖-1-磷酸作为底物,催化形成胸腺嘧啶二磷酸葡萄糖(TDP-glucose)或者尿嘧啶二磷酸葡萄糖(UDP-glucose),但对其他三种底物,无明显催化活性。【结论】大肠杆菌中表达纯化的核苷转移酶AmiE能够体外催化形成TDP-葡萄糖(或UDP-葡萄糖),确证了AmiE作为核苷转移酶的催化功能,同时表明AmiE对底物具有一定的选择性。     

硝磺草酮抗性菌株的筛选及抗性基因的克隆表达

【目的】从采集的土壤中筛选出硝磺草酮的抗性菌株,并从中克隆对羟苯基丙酮酸双加氧酶抗性基因。【方法】以酪氨酸为唯一碳源,采用富集培养法筛选分离硝磺草酮抗性菌株,利用16S rRNA基因序列分析对菌株进行初步鉴定。通过PCR扩增获得其HHPD基因序列,构建pETH4表达载体并在大肠杆菌Escherichia coli BL21(DE3)中进行异源表达。通过检测色素在440 nm处的吸收值分析菌株E. coli BL21(DE3)-pETH4对硝磺草酮的抗性特性。【结果】在含10 mmol/L硝磺草酮和1 g/L酪氨酸的选择培养基上,分离得到7株硝磺草酮抗性细菌,1株为不动杆菌属,2株为无色杆菌属,4株为假单胞菌属。从抗性最佳的Pseudomonas sp. AM-H4中扩增得到HPPD的基因片段为1 056 bp,其序列与Acinetobacter baumannii基因组中HPPD的基因序列相似性达到99%,341位点由天冬氨酸突变为丙氨酸。HPPD基因在大肠杆菌中实现异源表达,蛋白分子量大小约40 kD。菌株E. coli BL21(DE3)-pETH4在40 μmol/L硝磺草酮酪氨酸LB培养基中的色素吸收值显著降低,能够耐受高于200 μmol/L的硝磺草酮。【结论】克隆获得的HPPD具有良好的硝磺草酮抗性,将在新除草剂抗性作物选育中有一定的应用潜力。     

大肠杆菌BL21(DE3)膜组分相关基因的敲除对重组蛋白胞外分泌的影响

摘要:【目的】探究Escherichia coli BL21(DE3)中膜组分相关的脂多糖合成基因waaF或msbB的敲除对重组蛋白胞外分泌的影响。【方法】运用Red重组技术将E.coli BL21 (DE3)染色体上的基因waaF或msbB敲除,构建敲除菌株E.coli BL21(ΔwaaF)、E.coli BL21(ΔmsbB)。将本实验室保存的带有β-呋喃果糖苷酶(β-fructofuranosidase,β-FFase)、青霉素G 酰化酶(penicillin G acylase,PGA)基因的重组质粒pET-ffase、pET-pga分别转入敲除菌株及出发菌株中,构建工程菌株E.coli BL21(ΔmsbB)/pET-ffase、E.coli BL21(ΔwaaF)/pET-ffase、E.coli BL21(DE3)/pET-ffase、E.coli BL21(ΔmsbB)/pET-pga、E.coli BL21(ΔwaaF)/pET-pga、E.coli BL21(DE3)/pET-pga。最后通过摇瓶发酵研究敲除菌株对β-FFase、PGA胞外分泌的影响。【结果】当诱导表达4 h,以出发菌株E.coli BL21(DE3)为宿主时,β-呋喃果糖苷酶β-FFase的胞外分泌量占总表达量的2.6%,以敲除菌株ΔmsbB为宿主时,胞外分泌量达到19.7%,而以敲除菌株ΔwaaF为宿主时,胞外分泌量达到50.9%。另外,当诱导表达24 h,以敲除菌株ΔwaaF为宿主时,青霉素G酰化酶PGA的胞外酶活是出发菌株中的4.1倍,达到1708 U/L。【结论】本研究成功构建了敲除菌株ΔmsbB和ΔwaaF,ΔmsbB能明显增强β-FFase的胞外分泌,而ΔwaaF对β-FFase和PGA的胞外分泌均有显著的强化作用。     

大肠杆菌tRNASec关键核苷酸位点

在原核生物中,硒蛋白合成需要tRNA~(Sec) (SelC)与硒代半胱氨酸合成(Sec synthase, SelA)、硒代半胱氨酸特异性延伸因子(Sec-specificelongationfactor,SelB)之间相互作用。【目的】基于大肠杆菌掺硒机器,寻找tRNA~(Sec)骨架上关键核苷酸位点,为解决硒蛋白目前面临的掺硒效率较低、产量低的问题提供新思路。【方法】以大鼠细胞质型硫氧还蛋白还原酶(thioredoxinreductase1,TrxR1)为掺硒模式蛋白为定点突变tRNA~(Sec),转化至BL21 (DE3) gor-获得阳性重组菌株(携带pET-TRSter/pSUABC’),用于表达大鼠硒蛋白TrxR1,然后使用2￠,5￠ADP-Sepharose亲和层析和凝胶过滤两步法分离纯化TrxR1,最后利用经典硒依赖型DTNB还原反应测定TrxR1的酶活,分析关键核苷酸位点,评价掺硒效率。【结果】在存在SECIS元件的前提下,当SelA、SelB、tRNA~(Sec)共表达时,与野生型相比,携带突变型tRNA~(Sec)所共表达的TrxR1酶活力呈现不同程度的降低,其中E.colitRNA~(Sec)的G18、G19这两个位点的所有的TrxR1酶活远低于野生型(10%);然而,a26和b7的酶活相对较高。【结论】E. coli tRNA~(Sec)骨架上G18和G19位点对于维持tRNA稳定性和灵活性发挥了关键作用,位点突变引起tRNA结构变化会影响tRNA~(Sec)与掺硒元件的互作,因此有望通过改造tRNA核苷酸位点来提高硒蛋白的掺硒效率。     

Pseudomonas putida KT2440低特异性L-苏氨酸醛缩酶的表达、酶学性质及温度稳定性提高

【目的】从Pseudomonas putida KT2440基因组中,钓取低特异性L-苏氨酸醛缩酶基因(lta E),构建重组大肠杆菌。研究目标酶的酶学性质,和关键氨基酸位点突变对酶活和温度稳定性的影响。【方法】以P. putida KT2440基因组DNA为模板,PCR扩增出lta E基因,构建重组表达质粒p ET28a-KT2440并转化Escherichia coli BL21 (DE3),获得重组菌E. coli BL21 (DE3)/p ET-KT2440,利用Ni~(2+)柱亲和层析纯化低特异性L-苏氨酸醛缩酶(LTA),对关键氨基酸位点Thr206和Lys207实施定点突变。【结果】SDS-PAGE结果表明LTA在大肠杆菌中获得高效表达,分子量为40k Da左右,与理论值大小相符。Ni~(2+)柱亲和层析纯化LTA,获得单一条带。利用双酶耦联法测得LTA酶活为5577.3U/mg,最适反应温度为50°C,最适p H为8.0。在温度低于45°C,p H 5.0-9.0时,重组酶较稳定。LTA酶的Km和kcat值为23.95 mmol/L和19216.6 s–1。Mg~(2+)、Ca~(2+)金属离子对LTA有明显的促进作用,而Ni~(~(2+))、Cu~(2+)、Zn~(2+)、Fe~(2+)等对酶有明显的抑制作用。该酶在叔丁基甲基醚溶剂中具有良好的耐受性,在叔丁基甲基醚中保存1h后仍保留90%以上的酶活。Thr206Ser突变明显提高了酶对温度的稳定性。Lys207对酶催化功能是必需的,该位点突变对酶活都是致死的。【结论】克隆并表达P. putida KT2440的LTA酶,研究了酶学性质,通过定点改造提高了酶的温度稳定性,筛选获得一种酶耐受性好的有机溶剂,为LTA酶在有机溶剂中高效稳定催化β-羟基-α-氨基酸奠定了较坚实的研究基础。     

两种L-天冬氨酸α-脱羧酶的表达与酶学性质分析

【目的】实现单核增生李斯特菌(Listeria monocytogenes)和杰氏棒杆菌(Corynebacterium jeikeium)L-天冬氨酸α-脱羧酶基因在Escherichia coli中异源表达,纯化重组蛋白并对其进行酶学性质分析。【方法】依照E.coli的密码子偏好性优化来源于L.monocytotogens和C.jeikeium的pan D基因序列。人工合成后以此构建表达载体pET28a(+)-pan D_(Lm)和p ET28a(+)-pan D_(Cj),转化E.coli BL21(DE3),实现panD_(Lm)和panD_(Cj)基因的异源表达。利用亲和层析纯化获得携带组氨酸标签的纯酶后进行酶学性质研究,并考察底物对酶反应的影响。【结果】重组菌蛋白电泳分析结果表明,重组酶panD_(Lm)和panD_(Cj)均有自加工功能,裂解后形成了α亚基和β亚基。重组酶比酶活分别为8.9 U/mg和11.8 U/mg。两种酶的最适反应温度均为60°C,最适p H分别为7.0和6.0,它们都在30-50°C,酸性条件下较稳定。与目前研究最多的谷氨酸棒杆菌(Corynebacterium glutamicum)来源的Pan DC.g相比,Pan DL.m受底物天冬氨酸的抑制作用较小。【结论】panD_(Lm)和panD_(Cj)可在高温酸性条件下特异性转化L-天冬氨酸生成β-丙氨酸,其中panD_(Lm)受底物的抑制作用较小,具有一定的工业应用潜力。     

定点突变提高N-酰基高丝氨酸内酯酶酶活和温度稳定性

【目的】提高N-酰基高丝氨酸内酯酶(N-acylhomoserine lactonase,AiiA)酶活及温度稳定性。【方法】本研究基于AiiA同源蛋白的三维结构对AiiA进行定点突变,分析野生型AiiA及其突变蛋白酶活和温度稳定性。【结果】野生型AiiA较不稳定,在45℃下温浴30 min,或4℃储存5 d后均失去降解N-酰基高丝氨酸内酯(N-acylhomoserine lactone,AHL)的活性。但是突变AiiA蛋白(N65K,T195R和A206E)的酶活力较野生型AiiA均提高了20%以上,且4℃储存时间延长到7 d。此外,突变株N65K比野生型AiiA对高温具有更强的耐受性,在45℃温浴后剩余酶活力达到45%以上,55℃温浴30 min后仍保留5.0%的酶活力。【结论】通过定点突变改造AiiA蛋白结构,提升了AiiA蛋白的酶活和温度稳定性。     

arcA基因提高大肠杆菌对有机溶剂的耐受性

【目的】将来源于恶臭假单胞菌(Pseudomonas putida JUCT1)的基因arc A(编码精氨酸脱亚胺酶)整合到Escherichia coli JM109(DE3)基因组中,以提高该菌对有机溶剂的耐受性。【方法】以P.putida JUCT1的基因组为模板扩增基因arc A,并与p ET-20b(+)连接后导入E.coli JM109(DE3)中,验证该基因提高E.coli JM109(DE3)对有机溶剂的耐受性。利用Red同源重组的方法将arc A整合到E.coli JM109(DE3)基因组中。【结果】E.coli JM109(DE3)/p ET-20b(+)-arc A在添加了2.0%(体积比)环己烷、0.1%(体积比)甲苯、4.0%(体积比)萘烷和0.1%(体积比)丁醇的培养基中培养8 h后,其OD660由初始的0.2分别上升到0.8、0.9、1.8和1.3。将arc A成功整合到E.coli JM109(DE3)基因组中,获得了具有较好遗传稳定性的溶剂耐受E.coli JM109(DE3)宿主菌株。【结论】外源基因arc A能提高大肠杆菌菌株的有机溶剂耐受性,为工业化应用中耐溶剂微生物菌株的构建提供了实验依据和理论基础。     

A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility

正Dear Editor,In December 2019, a novel human coronavirus caused an epidemic of severe pneumonia(Coronavirus Disease 2019,COVID-19) in Wuhan, Hubei, China(Wu et al. 2020; Zhu et al. 2020). So far, this virus has spread to all areas of China and even to other countries. The epidemic has caused 67,102 confirmed infections with 1526 fatal cases     

Curcuminoids as inhibitors of thioredoxin reductase: A receptor based pharmacophore study with distance mapping of the active site

Curcumin is the yellow pigment of turmeric that interacts irreversibly forming an adduct with thioredoxin reductase (TrxR), an enzyme responsible for redox control of cell and defence against oxidative stress. Docking at both the active sites of TrxR was performed to compare the potency of three naturally occurring curcuminoids, namely curcumin, demethoxy curcumin and bis-demethoxy curcumin. Results show that active sites of TrxR occur at the junction of E and F chains. Volume and area of both cavities is predicted. It has been concluded by distance mapping of the most active conformations that Se atom of catalytic residue SeCYS498, is at a distance of 3.56 from C13 of demethoxy curcumin at the E chain active site, whereas C13 carbon atom forms adduct with Se atom of SeCys 498. We report that at least one methoxy group in curcuminoids is necessary for interation with catalytic residues of thioredoxin. Pharmacophore of both active sites of the TrxR receptor for curcumin and demethoxy curcumin molecules has been drawn and proposed for design and synthesis of most probable potent antiproliferative synthetic drugs.     

The structure, reproduction and taxonomy of Vidalia and Osmundaria (Rhodophyta, Rhodomelaceae)

Comprises species occurring mostly in subtidal habitats in tropical, subtropical and warm-temperate areas of the world. An analysis of the type species, V. spiralis (Sonder) Lamouroux ex J. Agardh, a species from Australia, establishes basic characters for distinguishing species in the genus. These characters are (1) branching patterns of thalli, (2) flat blades that may be spiralled on their axis, (3) width of the blade, (4) primary or secondary derivation of sterile and fertile branchlets and (5) position of sterile and fertile branchlets on the thalli. Application of the latter two characters provides an important basic method for separation of species into three major groups. Osmundaria , a genus known only in southern Australia, was studied in relation to Vidalia , and its separation from the Vidalia assemblage is not accepted. Species of Vidalia therefore are transferred to the older genus name, Osmundaria. Two new species, Osmundaria papenfussii and Osmundaria oliveae are described from Natal. Confusion in the usage of the epithet, Vidalia fimbriala Brown ex Turner has been clarified, and Vidalia gregaria Falkenberg, described as an epiphyte on Osmundaria pro/ifera Lamouroux, is revealed to be young branches of the host, Osmundaria prolifera.     

New or rare chromosome counts in Artemisia L. (Asteraceae, Anthemideae) and related genera from Kazakhstan

Fifteen chromosome counts of six Artemisia taxa and one species of each of the genera Brachanthemum, Hippolytia, Kaschgaria, Lepidolopsis and Turaniphytum are reported from Kazakhstan. Three of them are new reports, two are not consistent with previous counts and the remainder are confirmations of very scarce (one to four) earlier records. All the populations studied have the same basic chromosome number, x = 9, with ploidy levels ranging from 2x to 6x. Some correlations between ploidy level, morphological characters and distribution are noted.     

Comparative morphology of the carpel in the Liliaceae: Hewardieae, Petrosavieae, and Tricyrteae

The young pistils in the melanthioid tribes, Hewardieae, Petrosavieae and Tricyrteae, are uniformly tricarpellate and syncarpous. They lack raphide idioblasts. All are multiovulate, with bitegmic ovules. The Petrosavieae are marked by the presence of septal glands and incomplete syncarpy. Tepals and stamens adhere to the ovary in the Hewardieae and the Petrosavieae but not in the Tricyrteae. Two vascular bundles occur in the stamens of the Hewartlieae and Tricyrtis latifolia. Ventral bundles in the upper part of the ovary of the Hewardieae are continuous with compound septal bundles and placental bundles in the lower part. Putative ventral bundles occur in the alternate position in the Tricyrteae and putative placental bundles in the opposite. position in the Petrosavieae. The dichtomously branched stigma in each carpel of the Tricyrteae is supplied by a bifurcated dorsal bundle.     

肝癌中HBV和HCV基因和抗原的分布及意义

采用原位分子杂交方法检测HCV RNA及HBV X基因;采用免疫组织化学方法研究HCV核心抗原,非结构区C33c抗原及HBxAg在肝细胞肝癌中的定位及分布.结果表明(1)HCV RNA、HBV X基因在肝细胞肝癌组织检出率分别为40%(55/136)和82%(112/136).HCV RNA定位于癌细胞的胞浆内,阳性细胞呈散在、灶状及弥漫分布三种形式;HBV X基因在肝癌细胞中的分布呈胞浆型、核型及核浆型,阳性细胞也呈上述三种分布形式;(2)HCV C33c抗原、核心抗原在肝细胞肝癌中的阳性率为81%(133/164)及86%(141/164).C33c抗原定位于癌细胞及肝细胞的胞浆内;核心抗原既定位于癌细胞核中,又可定位于胞浆中.C33c抗原阳性细胞以灶状分布为主;而核心抗原阳性细